PharmaTalkRadio
431 episodes - English - Latest episode: 8 days ago - ★★★★ - 16 ratingsPharmaTalkRadio is an internet radio podcast platform organized and supported by the Conference Forum to give easy and free access to industry professionals, patient advocacy and students in medicine development. PharmaTalkRadio features industry insiders on the latest strategies, business models, and new innovations to advance clinical research with emphasis on clinical trials, patient- centricity, drug delivery, Immuno-oncology, digital, mobile and other technologies as well as leadership topics and emerging biotech challenges. Also featured on PharmaTalkRadio are podcasts covering a wide range of topics from Conference Forum events.
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
Taking Lessons from Manufacturing Immunotherapies to Accelerate Development
April 12, 2024 04:00 - 44 minutes - 39.7 MBFor more information, visit IO360summit.com.
Enhancing Solubility with Novel Excipient Technologies
April 08, 2024 04:00 - 31 minutes - 27.5 MBAs new drugs in development have poorer solubility and bioavailability, there is a need for novel solubility enhancing polymers to improve drug loading and improve patient adherence. In this podcast, Nick DiFranco explains some of the shortcomings of traditional solubility enhancers as well as key considerations for novel technologies. Nick also presents an overview of Lubrizol’s Apinovex™ polymers for oral solubility enhancement and Apisolex™ polymers for injectable solubility enhancement. ...
Measuring the Value of DCTs and Hybrid Models
April 02, 2024 04:00 - 32 minutes - 28.5 MBFor more information, visit DPHARMconference.com.
Navigating and Adopting Innovation in a Post- Pandemic World
March 29, 2024 04:00 - 26 minutes - 23.7 MBFor more information, visit DPHARMconference.com.
Turning a Search for Lung Cancer Biomarkers into a Patient Empowerment Community
March 15, 2024 04:00 - 21 minutes - 19.1 MBSummary: In this podcast, Terri Conneran tells the story of how her cancer diagnosis and a search for relevant biomarkers turned into KRAS Kickers, a cancer research advocate community. For more information on PharmaTalk Radio podcasts, visit theconferenceforum.org.
Engaging All Stakeholders for Clinical Trial Patient Engagement and Value
March 12, 2024 04:00 - 54 minutes - 49.3 MBFor more information, visit theconferenceforum.org.
Optimizing Medicine Development for Real-World Efficacy in Patients
February 26, 2024 05:00 - 25 minutes - 22.2 MBAbout the episode: It's estimated that only 20% of health outcomes are due to clinical care, with the remaining 80% as a result of social determinants of health. Medicine development leaders must understand the broader context of patient lives in order to create therapies with real-world efficacy. In this podcast, Noël Theodosiou tells us how she's working with life science companies, to understand and contextualize the real world that patients live in to create therapeutics that fit in t...
How CMOs can Support the Overarching Process of a Fundraising
January 30, 2024 05:00 - 27 minutes - 24.1 MBTo learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.
Prioritizing Development Programs that Align with Fundraising Catalysts
January 30, 2024 05:00 - 31 minutes - 28.3 MBTo learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.
Developing Internal and External Communication Strategies
January 29, 2024 05:00 - 32 minutes - 28.6 MBTo learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.
Interacting with Different Types of Investors as a CMO
January 29, 2024 05:00 - 41 minutes - 37.4 MBTo learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.
What CMOs Need to Know About Medical Affairs
January 28, 2024 05:00 - 31 minutes - 28 MBTo learn more about the Chief Medical Officer Summit 360°, please visit CMO360.org.
The Promise and Challenges of Ultrasound-Mediated Delivery
January 09, 2024 05:00 - 31 minutes - 27.6 MBTo learn more about the PODD: Partnership Opportunities in Drug Delivery Conference, please visit PODDConference.com.
Achieving Targeted Delivery of Gene Editing Therapies
January 09, 2024 05:00 - 30 minutes - 27 MBTo learn more about the PODD: Partnership Opportunities in Drug Delivery Conference, please visit PODDConference.com.
New Approaches in CNS/PNS Delivery
January 08, 2024 05:00 - 29 minutes - 26.3 MBTo learn more about the PODD: Partnership Opportunities in Drug Delivery Conference, please visit PODDConference.com.
The Future of Digital Technology in the Connected Device Space
January 08, 2024 05:00 - 32 minutes - 28.6 MBTo learn more about the PODD: Partnership Opportunities in Drug Delivery Conference, please visit PODDConference.com.
Precision Ophthalmic Delivery
January 07, 2024 05:00 - 29 minutes - 26.5 MBTo learn more about the PODD: Partnership Opportunities in Drug Delivery Conference, please visit PODDConference.com.
Delivery Challenges from the Oncology Pipeline
January 07, 2024 05:00 - 32 minutes - 28.5 MBTo learn more about the PODD: Partnership Opportunities in Drug Delivery Conference, please visit PODDConference.com.
Overcoming Barriers to Adoption of Transdermal Delivery
January 04, 2024 05:00 - 30 minutes - 26.9 MBTo learn more about the PODD: Partnership Opportunities in Drug Delivery Conference, please visit PODDConference.com.
Novel Nasal Products and Formulations
January 04, 2024 05:00 - 31 minutes - 28 MBTo learn more about the PODD: Partnership Opportunities in Drug Delivery Conference, please visit PODDConference.com.
Addressing the Clinical Operations Workforce Gap
December 20, 2023 05:00 - 31 minutes - 28 MBLearn more about the DPHARM: Disruptive Innovations to Modernize Clinical Research conference, visit DPHARMconference.com.
Evolving US Clinical Trial Infrastructure for Better Trials & Emergency Response
December 20, 2023 05:00 - 31 minutes - 28.1 MBTo learn more about the DPHARM: Disruptive Innovations to Modernize Clinical Research conference, visit DPHARMconference.com.
Patients on How R&D Organizations Can Better Operationalize Trials for Patients
December 14, 2023 05:00 - 39 minutes - 34.9 MBLearn more about Patients as Partners in Clinical Research at patientsaspartnersconference.com.
Community Organization Perspectives on Improving Clinical Trial Initiatives
December 14, 2023 05:00 - 1 hour - 57 MBFor more information on Patients as Partners in Clinical Research, visit patientsaspartnersconference.com.
How Henry Ford Health Integrated Clinical Trials into Clinical Care
October 26, 2023 04:00 - 35 minutes - 31.6 MBLearn more about CRAACO: Clinical Research as a Care Option, at CRAACOevent.com
Novartis’ Approach to Making Patients Feel Valued in Clinical Research
October 26, 2023 04:00 - 17 minutes - 14.9 MBLearn more about CRAACO: Clinical Research as a Care Option, at CRAACOevent.com
Democratizing Access: Enabling All Care Locations to be Research Locations
October 25, 2023 04:00 - 39 minutes - 34.8 MBLearn more about CRAACO: Clinical Research as a Care Option, at CRAACOevent.com
Reimbursement Challenges with Clinical Trials
October 25, 2023 04:00 - 22 minutes - 19.6 MBLearn more about CRAACO: Clinical Research as a Care Option, at CRAACOevent.com
Strategies for Building a Successful Clinical Research Team in the Care Setting
October 24, 2023 04:00 - 39 minutes - 35.6 MBLearn more about CRAACO: Clinical Research as a Care Option, at CRAACOevent.com
How to Optimize Inventory and Sample Management for Clinical Trial Health
October 04, 2023 04:00 - 24 minutes - 21.2 MBIn this Episode: As clinical trials become more complex, sampling schemes keep pace. That makes proper sample and inventory management so crucial. Slope's Hope Meely and Kyle Baker shed light on the intricacies and the complexities related to clinical inventory management and sample management. Listeners can learn more about clinical inventory involved for biospecimens, the challenges experienced in executing clinical trials and how these issues can be resolved. Speakers: Hope Meely,...
Ensuring That Sites Are Set Up for Trial Success, Using Data and Technology
August 29, 2023 04:00 - 28 minutes - 25.1 MBAbout the Episode: For those of us who work in clinical trials, we know all too well that the majority of sites don't hit recruitment targets, resulting in costly delays and burnout from sites and patients. Tegan Mead and Julie Mansson, both at Javara, describe how they are applying data and technology to identify the right fit and make sure that sites are set up for success, advising sponsors on making trials less burdensome for patients, and keeping physicians in the loop on trials for t...
Innovating Patient Recruitment: A Conversation with BBK Worldwide Founders
August 07, 2023 04:00 - 27 minutes - 24.5 MBInnovating Patient Recruitment: A Conversation with BBK Worldwide Founders Joan F. Bachenheimer and Bonnie A. Brescia The Conference Forum moderates a webcast featuring Joan F. Bachenheimer and Bonnie A. Brescia, the founders of BBK Worldwide, who walk us through the evolution of patient recruitment and engagement, the connection to the women’s and consumer healthcare movement, the need for changes in communication and the rise of the patient voice. They also address the impact of scient...
10th Annual Mobile Tech in Clinical Trials: What to Expect in under 10 Minutes
July 28, 2023 12:00 - 9 minutes - 7.78 MBDirectors, Valerie Bowling and Kate Woda, discuss what to expect at the upcoming 10th annual Mobile Tech in Clinical Trials conference taking place on September 19, 2023 in Boston, MA.
CRAACO Director's Note Podcast on What to Expect in Under 6 Minutes
May 10, 2023 12:00 - 6 minutes - 4.9 MBDirector, Valerie Bowling, reviews what to expect at the upcoming Clinical Research as a Care Option (CRAACO) conference taking place on May 22-23 at the Sheraton Imperial Hotel in Raleigh-Durham, NC.
Current Challenges in Vaccine Delivery and Distribution
January 23, 2023 14:00 - 29 minutes - 25.8 MBIn this podcast, you will hear a panel discussion moderated by Paul Jansen from the 2022 PODD Conference regarding the biggest challenges as well as future solutions to vaccine administration and distribution. Panelists include: Jeffrey T Blue, MerckDerek O’Hagan, PhD, GSK To learn more about the PODD Conference, please visit PODDConference.com.
Providing the Right Level of Value to the Patient that Creates Value
January 20, 2023 12:30 - 28 minutes - 25 MBIn this podcast, you will hear a panel discussion moderated by Mark DeStefano, Teva, from the 2022 PODD Conference regarding balancing the level of connected activity with user needs, determining how broadly or specifically to use connectivity and slowly implementing connectivity to provide good user acceptance. Panelists include: Kevin Deane, Phillips-Medisize, a Molex CompanyDavid Harrison, UCBLilly StairsBrad Womble, JabilAndrei Yosef, Eitan Medical To learn more about the PODD Conference...
Enhancing the Interferon Pathway to Attack Cancer
January 19, 2023 14:30 - 20 minutes - 17.4 MBWhy is enhancing the interferon pathway an attractive approach for treating cancer?What are the novel therapeutic approaches being investigated to harness the innate immune system to enhance the interferon pathway to treat cancer?What are the translational approaches being applied to better study therapeutics that activate the interferon pathway against hematologic and solid tumors and identify the patients who may respond better to these therapeutics? Christine Ward, PhD, Head, oncology Pr...
Innovative CRISPR-based Editing to Create Off-the-shelf Immune Cell Therapies
January 18, 2023 14:30 - 26 minutes - 23.4 MBIn this talk, first recorded at the 2022 IO360° Summit, Dr Rachel Haurwitz, CEO, Caribou Biosciences, addresses the big picture view of where the cell therapy field is going and how innovative CRISPR-based editing will help with the treatment of hematologic and solid tumors. Key topics include: Approach that requires highly specific and efficient multiplex genome editingWhat are some of the potential stumbling blocks?What are the tools for solving those challenges?Tackling solid tumors as the...
Investment Trends in IO
January 17, 2023 14:30 - 45 minutes - 41 MBModerated by: Axel Hoos, MD, PhD, CEO, Scorpion Therapeutics Panelists: Jonathan Fassberg, Vice Chairman of Healthcare Investment Banking, OppenheimerIrina Margine, PhD, Principal, Biotech Private Equity, Wellington ManagementAsthika Goonewardene, MBA, Managing Director, Senior Biotech Analyst, Truist SecuritiesGraig Suvannavejh, PhD, Managing Director, Equity Research Biopharmaceuticals & Biotechnology, Mizuho Securities USA Learn more about the IO360° Summit at www.io360summit.com
Investment and Collaboration Strategies in Cell and Gene Therapy
January 16, 2023 17:30 - 42 minutes - 38.1 MBThis panel, first recorded at the 2022 IO360° Summit addressed: What are the risks and implications of investing in cell/gene therapy companies who have no clinical data from programs available?Venture company perspectives on what they are investing in and why? • What science needs to be seen in order to invest in either a startup or IPO?What are investors/pharma partners looking for and how does that inform what people should be doing?How do we think about partnerships between organizations?...
Mechanisms of Immune Evasion Mediated by Hypoxia- Inducible Factors
January 14, 2023 16:00 - 23 minutes - 21 MBIn this session, first recorded at the 2022 IO360° Summit, Dr Semenza will talk about how his work is impacting cancer immunotherapy. Dr Semenza’s groundbreaking discovery of hypoxia-inducible factors paves the way for the development of drugs that could kill cancer cells by cutting off the oxygen supply tumors need to grow and improve the response to immunotherapies. Key areas addressed include: Regions of intratumoral hypoxia are a common feature of advanced cancersHypoxia-inducible factors...
Neoadjuvant Immune Checkpoint Blockade: A Window into Treatment Response and Pri
January 13, 2023 18:00 - 27 minutes - 24.1 MBNeoadjuvant (pre-surgical) immune checkpoint blockade may prevent cancer relapse and progression.This treatment approach is now FDA-approved for resectable triple-negative breast cancer, and hundreds of clinical trials in other cancers are ongoing.Surgical resection specimens collected after several weeks of neoadjuvant ICB offer vast opportunities for predictive biomarker discovery and understanding ICB response/resistance. Suzanne Topalian, MD, Associate Director / Professor of Surgery, Blo...
Regeneron’s Approach to Strategic Collaborations, Licensing and Business Dev.
January 12, 2023 17:30 - 22 minutes - 19.7 MBNouhad Husseini, MBA, SVP, Business Development and Corporate Strategy, Regeneron Pharmaceuticals with Allan Shaw, CFO / Founder & Senior Managing Director, Portage Biotech / Shaw Strategic Capital, LLC Learn more about the IO360 Summit at www.io360summit.com
Panel: Targeted Radiotherapy and the Impact on IO
January 11, 2023 14:30 - 31 minutes - 27.8 MBWhat is the impact of targeted radiotherapy on the immune system?What are the implications for combination IO?Current approaches and future direction Moderated by: Michael Groaning, PhD, Global Medical Affairs Lead, Genitourinary, Amgen Panelists: Charles Glaus, PhD, Sr Director, Radiomics & Radiology Biomarkers, Bayer US-PharmaceuticalsJeff Legos, PhD, MBA, EVP, Global Head of Oncology & Hematology Development , NovartisMatthew Silva, PhD, CEO , InvicroOhad Ilovich, PhD, Senior Director, T...
What’s Next on the IO Radar? Top 10 Recommendations from Dr Andrew Baum, Citi
January 10, 2023 15:00 - 27 minutes - 24.2 MBLearn more about the IO360° Summit at www.io360summit.com
KEYNOTE FIRESIDE CHAT with Dr Robert Langer and Dr Ester Caffarel-Salvador
January 10, 2023 12:30 - 36 minutes - 32.2 MBIn this podcast, you will hear a keynote fireside discussion with Dr Robert Langer, MIT, and Dr Ester Caffarel-Salvador, Chiesi USA, from the 2022 PODD Conference regarding current projects in the Langer Lab, how COVID affected the lab’s dynamics and collaborations, challenges in the drug delivery space, and exciting technologies in the pipeline, To learn more about the PODD Conference, please visit PODDConference.com.
Panel: Role of China in the BD Process
January 09, 2023 16:00 - 31 minutes - 27.9 MBThis panel, first recorded at the 2021 Immuno-Oncology 360° Summit, will bring together chinese biotechs to share how they are partnering with additional IO companies to advance cancer treatments for patients. This will include partnering strategies and decision making. To learn more about the IO360° Summit visit, www.io360summit.com
Gaining “Hard-to-Reach” Patients’ Input During the Global COVID Pandemic
January 06, 2023 13:00 - 19 minutes - 17.1 MBIn this session, GSK shares how they delivered on patient and caregiver engagements, especially with communities experiencing the highest COVID burden. They gained insights on study designs, educational pieces and captured patient experiences to enhance HCP/public COVID awareness. GSK will discuss: Value of COVID engagements Novel approaches and mechanisms for finding patients who don’t belong to an organized patient community Overcoming challenges How this initiative could be modeled to ...
How Janssen is Collaboratively Working with Patients and Sites to Advance DCTs
January 05, 2023 13:00 - 18 minutes - 16.4 MBIn this session, Janssen shares how they are collaboratively working with patients and sites to advance DCTs and will share engagement methodologies, what they have learned from the perspective of participants and sites, and the direction this has taken them in DCTs. Alyson Gregg, Director Patient Insights, GMA Commercial Operations, Janssen Morgan Wooten, Investigator & Patient Engagement Program Team Leader, Janssen Learn more about the Patients as Partners in Clinical Research confere...
How Merck is Partnering with Communities to Support Clinical Research
January 04, 2023 13:00 - 21 minutes - 18.6 MBMerck’s iLab53 (a modular 39-foot mobile unit) was used to bring clinical research into community settings as an effort to increase clinical trial awareness and engagement. More specifically: How the iLab53 was created and implemented How Merck is continuing to work to help build trust within communities, and provide increased access to clinical research Challenges, learnings and successes to date How this initiative can be scaled and adapted Susan Manoff, MD, MPH, Executive Director, O...